Загрузка...
Four-Week Studies of Oral Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia
Hypoxia-inducible factor prolyl hydroxylase inhibitors stabilize levels of hypoxia-inducible factor that upregulate transcription of multiple genes associated with the response to hypoxia, including production of erythropoietin. We conducted two phase 2a studies to explore the relationship between t...
Сохранить в:
| Опубликовано в: : | J Am Soc Nephrol |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Nephrology
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4814173/ https://ncbi.nlm.nih.gov/pubmed/26494831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2014111139 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|